Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53
出版年份 2012 全文链接
标题
Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53
作者
关键词
-
出版物
EMBO Molecular Medicine
Volume 4, Issue 6, Pages 515-527
出版商
EMBO
发表日期
2012-03-13
DOI
10.1002/emmm.201200229
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Exploiting synthetic lethal interactions for targeted cancer therapy
- (2011) H. Christian Reinhardt et al. CELL CYCLE
- How phosphorylation controls p53
- (2011) Nicola J. Maclaine et al. CELL CYCLE
- PARP inhibitors stumble in breast cancer
- (2011) Malini Guha NATURE BIOTECHNOLOGY
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
- (2011) Joyce O'Shaughnessy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells
- (2011) A. G. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of mRNA decay in p53-induced gene expression
- (2011) B. D. Melanson et al. RNA
- The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
- (2010) V. J. Weston et al. BLOOD
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop
- (2010) Michael E. Williams et al. LEUKEMIA & LYMPHOMA
- ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors
- (2010) C. T. Williamson et al. MOLECULAR CANCER THERAPEUTICS
- Preventing Nonhomologous End Joining Suppresses DNA Repair Defects of Fanconi Anemia
- (2010) Adele Adamo et al. MOLECULAR CELL
- Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway
- (2010) P. Pace et al. SCIENCE
- Targeting homologous recombination repair defects in cancer
- (2010) Bastiaan Evers et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining
- (2009) Brandi L. Mahaney et al. BIOCHEMICAL JOURNAL
- The combined status of ATM and p53 link tumor development with therapeutic response
- (2009) H. Jiang et al. GENES & DEVELOPMENT
- Altered States of Telomere Deprotection and the Two-Stage Mechanism of Replicative Aging
- (2009) Y. Zou et al. MOLECULAR AND CELLULAR BIOLOGY
- Essential Role for DNA-PKcs in DNA Double-Strand Break Repair and Apoptosis in ATM-Deficient Lymphocytes
- (2009) Elsa Callén et al. MOLECULAR CELL
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanism of Eukaryotic Homologous Recombination
- (2008) Joseph San Filippo et al. Annual Review of Biochemistry
- A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity
- (2008) Christopher J. Lord et al. DNA REPAIR
- A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor
- (2008) Nicholas C Turner et al. EMBO JOURNAL
- ATM Signaling Facilitates Repair of DNA Double-Strand Breaks Associated with Heterochromatin
- (2008) Aaron A. Goodarzi et al. MOLECULAR CELL
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
- Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
- (2008) Martin F. Lavin NATURE REVIEWS MOLECULAR CELL BIOLOGY
- High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
- (2008) S. Rottenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression status of ataxia-telangiectasia-mutated gene correlated with prognosis in advanced gastric cancer
- (2007) Bin Kang et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now